This article was printed from The Miller School of Medicine Medical News
at the following URL: https://news.med.miami.edu/sylvester-researcher-finds-fda-approved-antiviral-drug-can-be-delivered-via-nanoparticle-for-covid-19/

Copyright © 2025 University of Miami Health System